Sources | Names Used |
---|---|
CTRPv2 | BRD-K71935468 |
PharmacoGx | BRD-K71935468 |
Database | Identifier |
---|---|
Smiles: | COC(=O)C(CC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N8CCN(CC8)c9ncccn9)c2c1)C(=O)OC |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NDUFA13 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NIPA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PDE4B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | HEBP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BTF3L4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CHD1L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | UNC80 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | PSMD7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PPP2R5B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | SLC39A14 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |